1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Ear Care in France

Ear Care in France

  • June 2013
  • -
  • Euromonitor International
  • -
  • 26 pages

In September 2012, Otipax, a common ear care product in France, was fully delisted from the official reimbursement list (listed at a 15% reimbursement rate until August 2012). This clearly confirms the ongoing impetus of the French authorities to continue de-reimbursement for benign ear care products, despite the arrival of the newly elected socialist government in May 2012, and in spite of political communication over a possible halt on the de-reimbursement spree. This was a de-reimbursement...

Euromonitor International's Ear Care in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?

* Get a detailed picture of the Ear Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Table Of Contents

Ear Care in France
EAR CARE IN FRANCE
Euromonitor International
June 2013


LIST OF CONTENTS AND TABLES


Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Ear Care: Value 2007-2012
Table 2 Sales of Ear Care: % Value Growth 2007-2012
Table 3 Ear Care Company Shares by Value 2008-2012
Table 4 Ear Care Brand Shares by Value 2009-2012
Table 5 Forecast Sales of Ear Care: Value 2012-2017
Table 6 Forecast Sales of Ear Care: % Value Growth 2012-2017
Executive Summary
De-reimbursement Keeps Growing in France
France Welcomes the Approved List of Health and Nutrition Claims
Ameli Pushes for More Generics
Growing Competition Between Pharmacists and Other Distribution Channels
Moderate Growth Is Expected in the Forecast Period
Key Trends and Developments
the French Government Continues Its De-reimbursement Policy Because of Mounting Economic Problems in the Country
EU Adopts Vitamins and Dietary Supplements Approved List of Health and Nutrition Claims: Roadmap for Harmonisation in France
French Bodies Push for More Generic Drugs
Chemists/pharmacies Is Still the Most Frequented Channel for Consumer Health, But Faces Growing Competition
A Lethargic Socio-culture Impedes the Development of Self-medication
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 8 Life Expectancy at Birth 2007-2012
Market Data
Table 9 Sales of Consumer Health by Category: Value 2007-2012
Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 11 Consumer Health Company Shares 2008-2012
Table 12 Consumer Health Brand Shares 2009-2012
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 15 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Advertising
Vitamins and Dietary Supplements Registration and Classification
Distribution Channels
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC: Switches 2011-2012
Definitions
Sources
Summary 2 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Receive information concerning the dynamics and forecasts in the OTC drugs and dietary supplements market - Receive information pertaining to the major regional trends in the global ...

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global Over the Counter (OTC) Drugs Market

Global Over the Counter (OTC) Drugs Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

Download Unlimited Documents from Trusted Public Sources

OTC Markets in the US

  • March 2017
    10 pages
  • Pancreatic Canc...  

    Vitamin  

  • United States  

View report >

OTC Industry in the US

  • March 2017
    89 pages
  • OTC  

  • United States  

View report >

OTC Supply in the US

  • March 2017
  • Dietary Supplem...  

  • United States  

View report >

Otc Markets In Europe

21 days ago

Otc Industry In China

22 days ago

Otc Markets In Canada

23 days ago

Related Market Segments :

OTC
Vitamin
Dietary Supplement

ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.